Your DISPENSARY Tips as at 26 November 2015

Size: px
Start display at page:

Download "Your DISPENSARY Tips as at 26 November 2015"

Transcription

1 This information has been prepared to provided some essential buying tips for the upcoming months. It is designed to be used in conjunction with the full text documents contained within the Pharmac Updates segment of the company Website. N.B. Grey shading indicates additions in last 7 days. Your DISPENSARY Tips as at 26 November 2015 November 2015 Apo-Diclo Tab EC 25 mg; 100 tablet, bottle pack Price & Subsidy DECREASE of % in Schedule 01 Apo-Diclo Tab EC 50 mg; 500 tablet, bottle pack Price & Subsidy DECREASE of % in Schedule 01 Apo-Zopiclone Tab 7.5 mg; 500 tablet, bottle pack Reference Pricing to Zopiclone Actavis (Actavis), effective subsidy DECREASE of % in Schedule 01 Cosopt Eye drops 2% with timolol 0.5%; 5 ml OP Reference Pricing to Dortim-Arrow (Actavis), effective subsidy DECREASE of % in Schedule 01 Desferal Inj 500 mg vial; 10 vials New Listing with effective Price & Subsidy DECREASE of % in Schedule 01 Diclax SR Tab long-acting 100 mg; 500 tablet, bottle pack Reference Pricing to Apo-Diclo SR (Apotex), effective subsidy DECREASE of % in Schedule 01 Diclax SR Tab long-acting 75 mg; 500 tablet, bottle pack Reference Pricing to Apo-Diclo SR (Apotex), effective subsidy DECREASE of % in Schedule 01 Doxorubicin Ebewe Inj 2 mg per ml, 100 ml vial; 1 vial Price & Subsidy DECREASE of % in Schedule 01 Doxorubicin Ebewe Inj 2 mg per ml, 25 ml; 1 vial Price & Subsidy DECREASE of % in Schedule 01 Metformin-Apo Tab immediate release 850 mg; 500 tablet, bottle pack Reference Pricing to Metformin-Mylan (Mylan), effective subsidy DECREASE of % in Schedule Page 1 of 6 26/11/2015

2 m-nystatin Oral liq 100,000 u per ml; 24 ml OP, bottle with dropper New Listing with effective Price & Subsidy DECREASE of % in Schedule 01 Product not available until late January, early February Oxy Norm Oxy Norm Panadol Panadol Pizaccord Pizaccord Pizaccord pms-bosentan pms-bosentan Tracleer Tracleer Inj 10 mg per ml, 1 ml ampoule; 5 ampoules New Listing with effective Price & Subsidy DECREASE of % in Schedule 01 Inj 10 mg per ml, 2 ml ampoule; 5 ampoules New Listing with effective Price & Subsidy DECREASE of % in Schedule 01 Suppos 125 mg; 20 suppositories Reference Pricing to Gacet (AFT), effective subsidy DECREASE of -1.47% in Schedule 01 Suppos 250 mg; 20 suppositories Reference Pricing to Gacet (AFT), effective subsidy DECREASE of % in Schedule 01 Tab 15 mg; 28 tablet, blister pack Reference Pricing to Vexazone (Mylan), effective subsidy DECREASE of % in Schedule 01 Tab 30 mg; 28 tablet, blister pack Reference Pricing to Vexazone (Mylan), effective subsidy DECREASE of % in Schedule 01 Tab 45 mg; 28 tablet, blister pack Reference Pricing to Vexazone (Mylan), effective subsidy DECREASE of % in Schedule 01 Tab 125 mg; 56 tablet, blister pack of % in Schedule 01 Tab 62.5 mg; 60 tablet, blister pack of % in Schedule 01 Tab 125 mg; 56 tablet, blister pack of % in Schedule 01 Tab 62.5 mg; 60 tablet, blister pack of % in Schedule 01 December 2015 Page 2 of 6 26/11/2015

3 Aqueous Crm; SLS-free 500 g, pot New Listing with effective Price & Subsidy INCREASE of 1.53% in Schedule 01 Jan 16. Citalopram-Arrow Tab 20 mg; 84 tablet, blister pack Reference Pricing to Citalopram-PSM (API), effective subsidy DECREASE of % in Schedule 01 Jan 16. THANKS TO SUPPLIER FOR PRICE SUPPORT, WE WILL DROP OUR PRICE ON 12 Sep 15. Dexamethasone Tab 1 mg; 100 tablet, bottle pack Reference Pricing to Dexmethsone (Aspen), effective subsidy DECREASE of % in Schedule 01 Jan 16. Dexamethasone Tab 4 mg; 100 tablet, bottle pack Reference Pricing to Dexmethsone (Aspen), effective subsidy DECREASE of % in Schedule 01 Jan 16. Dulcolax Suppos 10 mg; 6 suppositories, foil pack Reference Pricing to Lax-Suppositories (AFT), effective subsidy DECREASE of % in Schedule 01 Jan 16. Humira Inj 20 mg per 0.4 ml prefilled syringe Price & Subsidy DECREASE of % in Schedule 01 Jan 16. Humira Inj 40 mg per 0.8 ml prefilled syringe Price & Subsidy DECREASE of % in Schedule 01 Jan 16. HumiraPen Inj 40 mg per 0.8 ml prefilled pen Price & Subsidy DECREASE of % in Schedule 01 Jan 16. Letraccord Tab 2.5 mg; 30 tablet, blister pack Reference Pricing to Letrole (Mylan), effective subsidy DECREASE of % in Schedule 01 Jan 16. Lisinopril-Arrow Tab 10 mg; 90 tablet, blister pack Reference Pricing to Lisinopril-Ethics (Multichem), effective subsidy DECREASE of % in Schedule 01 Jan 16. Lisinopril-Arrow Tab 20 mg; 90 tablet, blister pack Reference Pricing to Lisinopril-Ethics (Multichem), effective subsidy DECREASE of % in Schedule 01 Jan 16. Lisinopril-Arrow Tab 5 mg; 90 tablet, blister pack Reference Pricing to Lisinopril-Ethics (Multichem), effective subsidy DECREASE of % in Schedule 01 Jan Page 3 of 6 26/11/2015

4 Nausicalm Oxaliccord Oxaliccord Solox Solox Vaclovir Vfend Vfend Tab 50 mg; 10 tablet, blister pack Reference Pricing to Nauzene (Actavis), effective subsidy DECREASE of % in Schedule 01 Jan 16. Inj 5 mg per ml, 10 ml vial; 1 vial New Listing with effective Price & Subsidy DECREASE of % in Schedule 01 Jan 16. Inj 5 mg per ml, 20 ml vial; 1 vial New Listing with effective Price & Subsidy DECREASE of % in Schedule 01 Jan 16. Cap 15 mg; 28 capsule. blister pack Reference Pricing to Lanzol Relief (Mylan), effective subsidy DECREASE of % in Schedule 01 Jan 16. Cap 30 mg; 28 capsule, blister pack Reference Pricing to Lanzol Relief (Mylan), effective subsidy DECREASE of % in Schedule 01 Jan 16. Tab 500 mg; 30 tablet, blister pack New Listing with effective Price & Subsidy DECREASE of % in Schedule 01 Jan 16. Tab 200 mg; 56 tablet, blister pack Reference Pricing to Vttack (Mylan), effective subsidy DECREASE of % in Schedule 01 Jan 16. Tab 50 mg; 56 tablet, blister pack Reference Pricing to Vttack (Mylan), effective subsidy DECREASE of % in Schedule 01 Jan 16. Cap 20 mg; 60 capsule, blister pack % in Schedule 01 Jan 16. Cap 40 mg; 60 capsule, blister pack % in Schedule 01 Jan 16. Cap 60 mg; 60 capsule, blister pack % in Schedule 01 Jan 16. Cap 80 mg; 60 capsule, blister pack % in Schedule 01 Jan 16. January 2016 Page 4 of 6 26/11/2015

5 Desferrioxamine Dexamethasone- Max Health Dexamethasone- Max Health Doxorubicin Glycopyrronium bromide- Max Health Inj 500 mg vial; 10 vials Reference Pricing to Desferal (Novartis), effective subsidy DECREASE of % in Schedule Inj 4 mg per ml, 1 ml ampoule 10 Price & Subsidy DECREASE of % in Schedule Inj 4 mg per ml, 2 ml ampoule 5 Price & Subsidy DECREASE of % in Schedule Inj 1 mg for ECP (per 1 mg) Price & Subsidy DECREASE of % in Schedule Inj 200 mcg per ml, 1 ml ampoule 10 Price & Subsidy DECREASE of % in Schedule Metoprolol-AFT CR Tab 190 mg; blister pack 90 New Listing with effective Price & Subsidy DECREASE of % in Schedule Metoprolol-AFT CR Tab mg; blister pack 90 New Listing with effective Price & Subsidy DECREASE of % in Schedule Metoprolol-AFT CR Tab 47.5 mg; blister pack 90 New Listing with effective Price & Subsidy DECREASE of % in Schedule Metoprolol-AFT CR Tab 95 mg; blister pack 90 New Listing with effective Price & Subsidy DECREASE of % in Schedule Neostigmine metilsulfate with glycopyrronium bromide-max Health Nilstat Inj 2.5 mg with glycopyrronium bromide 0.5 mg per ml, 1 ml ampoule 10 Price & Subsidy DECREASE of % in Schedule HOSP Oral liq 100,000 u per ml; 24 ml OP, bottle with dropper Reference Pricing to m-nystatin (Multichem), effective subsidy DECREASE of % in Schedule Oxycodone Orion Inj 10 mg per ml, 1 ml ampoule; 5 ampoules Reference Pricing to Oxy Norm (Mundipharma), effective subsidy DECREASE of % in Schedule Oxycodone Orion Inj 10 mg per ml, 2 ml ampoule; 5 ampoules Reference Pricing to Oxy Norm (Mundipharma), effective subsidy DECREASE of % in Schedule February 2016 healthe Fatty Cream Crm; 500 g Reference Pricing to O/W Fatty Emulsion Cream (Boucher), effective subsidy DECREASE of % in Schedule 01 Mar 16. THANKS TO SUPPLIER FOR PRICE SUPPORT, WE WILL DROP OUR PRICE ON 11 Oct 15. To be DELISTED 01 Jun Oxaliplatin Inj 1 mg for ECP Price & Subsidy DECREASE of % in Schedule 01 Mar Page 5 of 6 26/11/2015

6 Valtrex Tab 500 mg; 30 tablet, blister pack Reference Pricing to Vaclovir (Mylan), effective subsidy DECREASE of % in Schedule 01 Mar 16. To be DELISTED 01 Jun DISCLAIMER: This information has been prepared and maintained to assist pharmacies in keeping up to date with the frequent changes to products listed on the Pharmaceutical Schedule. Although every effort has been made in compiling and checking the data to ensure that it is accurate, the authors, the publisher, and their servants or agents shall not be responsible for the continued currency of the information, or for errors, omissions or inaccuracies in this publication whether arising from negligence or otherwise whosoever or for any consequences arising there from. The information contained in this spreadsheet is copyright. Please seek the editors permission before distributing to another party. Copyright: Pharmacy Retailing (NZ) Ltd 2012 Page 6 of 6 26/11/2015

Your DISPENSARY Tips as at 11 March 2016

Your DISPENSARY Tips as at 11 March 2016 This information has been prepared to provided some essential buying tips for the upcoming months. It is designed to be used in conjunction with the full text documents contained within the Pharmac Updates

More information

Price Changes advised by Pharmac As at 12 June 2015

Price Changes advised by Pharmac As at 12 June 2015 s advised by Pharmac New to be available ex Manufacturer from 12th of preceding month. From Wholesale from date of supplier support which could vary. Product Supplier Schedule % + or - 01 Jun 15 31 Oct

More information

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes 28 April 2017 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2016/17 Invitation to Tender, d 3 November

More information

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 28 February 2014

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 28 February 2014 28 February 2014 TENDER RESULTS PHARMAC has resolved to award tenders for for Sole Subsidised Supply Status and Status for some products included in the Invitation to Tender, dated 07 November 2013. Some

More information

Price Changes advised by Pharmac As at 02 July 2015

Price Changes advised by Pharmac As at 02 July 2015 s advised by Pharmac New to be available ex Manufacturer from 12th of preceding month. From Wholesale from date of supplier support which could vary. Product Supplier Schedule 01 Jul 15 29 May 15 Irinotecan

More information

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 30 May 2014

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 30 May 2014 30 May 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2012/13 Invitation to Tender, dated 31 October

More information

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes 30 June 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2012/13 Invitation to Tender, dated 31 October

More information

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 30 April 2014

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 30 April 2014 30 April 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2012/13 Invitation to Tender, dated 31 October 2012 and

More information

2007/08 Tender. Current Subsidy and price. Bendrofluazide Tab 5 mg; 500 tablets, bottle $21.50 $11.75 Arrow-Bendrofluazide (Arrow)

2007/08 Tender. Current Subsidy and price. Bendrofluazide Tab 5 mg; 500 tablets, bottle $21.50 $11.75 Arrow-Bendrofluazide (Arrow) 31 March 2010 TENDER RESULTS The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept tenders for Sole Subsidised Supply and Status for some of the products included in the

More information

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes 29 February 2016 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2014/15 Invitation to Tender, d 6 November 2014, and

More information

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 31 October 2014

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 31 October 2014 31 October 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2012/13 Invitation to Tender, dated 31 October 2012 and

More information

Pharmaceutical Management Agency. Section H Update. for Hospital. Pharmaceuticals. Effective 1 August 2018

Pharmaceutical Management Agency. Section H Update. for Hospital. Pharmaceuticals. Effective 1 August 2018 Pharmaceutical Management Agency Section H Update for Hospital Pharmaceuticals Effective 1 August 2018 Contents Summary of decisions effective 1 August 2018... 3 Section H changes to Part II... 8 Index...

More information

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 19 December 2014

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 19 December 2014 19 December 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2012/13 Invitation to Tender, dated 31 October 2012

More information

Pharmaceutical Management Agency. Section H Update. for Hospital. Pharmaceuticals. Effective 1 December 2018

Pharmaceutical Management Agency. Section H Update. for Hospital. Pharmaceuticals. Effective 1 December 2018 Pharmaceutical Management Agency Section H Update for Hospital Pharmaceuticals Effective 1 December 2018 Contents Summary of decisions effective 1 December 2018... 3 Section H changes to Part II... 4 Index...

More information

Section H. Pharmaceuticals. New Zealand Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML)

Section H. Pharmaceuticals. New Zealand Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML) The Hospital Medicines List (HML) Section H for Hospital Management Agency Pharmaceuticals Update Update effective 1 August 2014 New Zealand Pharmaceutical Schedule Effective 1 July 2013 Cumulative for

More information

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes 31 August 2016 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2015/16 Invitation to Tender, d 6 November

More information

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes 28 February 2017 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2015/16 Invitation to Tender, d 6 November 2015 and

More information

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes 28 February 2017 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2015/16 Invitation to Tender, d 6 November 2015 and

More information

Section H. Pharmaceuticals. New Zealand. Pharmaceutical Schedule. Effective 1 July for Hospital. Update effective 1 October 2015

Section H. Pharmaceuticals. New Zealand. Pharmaceutical Schedule. Effective 1 July for Hospital. Update effective 1 October 2015 The Hospital Medicines List (HML) Section H for Hospital Pharmaceuticals Pharmaceutical Management Agency Update Update effective 1 October 2015 New Zealand Cumulative for August, September, and October

More information

Release of the 2017/18 Invitation to Tender

Release of the 2017/18 Invitation to Tender 2 November 2017 Release of the 2017/18 Invitation to Tender The 2017/18 Invitation to Tender (2017/18 ITT) has been distributed today. If you have already registered your e-mail address with PHARMAC s

More information

Approval of proposals for various pharmaceuticals

Approval of proposals for various pharmaceuticals 9 August 2010 Approval of proposals for various pharmaceuticals PHARMAC is pleased to announce the approval of proposals for pharmaceuticals in several therapeutic groups which aim to address some issues

More information

Proposal relating to the funding of TNF inhibitors (Humira and Enbrel) and gabapentin (Neurontin)

Proposal relating to the funding of TNF inhibitors (Humira and Enbrel) and gabapentin (Neurontin) 14 July 2015 Proposal relating to the funding of TNF inhibitors (Humira and Enbrel) and gabapentin (Neurontin) PHARMAC is seeking feedback on a proposal relating to the funding of the TNF-inhibitor medicines

More information

Release of the 2014/15 Invitation to Tender

Release of the 2014/15 Invitation to Tender 6 November 2014 Release of the 2014/15 Invitation to Tender The 2014/15 Invitation to Tender (2014/15 ITT) has been distributed today. Please note that the Electronic Portal will not be available until

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 November 2015 Cumulative for September, October and November 2015 Contents Summary of PHARMAC decisions effective

More information

Update New Zealand Pharmaceutical Schedule Effective 1 December 2016 Cumulative for September, October, November and December 2016

Update New Zealand Pharmaceutical Schedule Effective 1 December 2016 Cumulative for September, October, November and December 2016 Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 December 2016 Cumulative for September, October, November and December 2016 Contents Summary of PHARMAC decisions

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 October 2015 Cumulative for September and October 2015 Contents Summary of PHARMAC decisions effective 1 October

More information

Update New Zealand Pharmaceutical Schedule Effective 1 May 2016

Update New Zealand Pharmaceutical Schedule Effective 1 May 2016 Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 May Contents Summary of PHARMAC decisions effective 1 May... 3 Sumatriptan update on Sumatriptan injections... 4

More information

Advance Notification of Amendments to the March 2017 Drug Tariff

Advance Notification of Amendments to the March 2017 Drug Tariff Advance Notification of Amendments to the March 2017 Drug Tariff ADDITIONS Part I - Drugs And Preparations Special Container Drug Qty Price Acetylcysteine 600mg capsules 30 39.95 A Caffeine citrate 50mg/5ml

More information

Update New Zealand Pharmaceutical Schedule Effective 1 April 2016 Cumulative for January, February, March and April 2016

Update New Zealand Pharmaceutical Schedule Effective 1 April 2016 Cumulative for January, February, March and April 2016 Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 April 2016 Cumulative for January, February, March and April 2016 Contents Summary of PHARMAC decisions effective

More information

Section H. Pharmaceuticals. New Zealand. Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML)

Section H. Pharmaceuticals. New Zealand. Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML) The Hospital Medicines List (HML) Section H for Hospital Pharmaceuticals Pharmaceutical Management Agency Update Update effective 1 May 2014 New Zealand Cumulative for April and May 2014 Pharmaceutical

More information

10 Musculoskeletal and Joint Diseases

10 Musculoskeletal and Joint Diseases 10 Musculoskeletal and Joint Diseases To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and British Society of Rheumatology guidelines and guidance

More information

Section H. Pharmaceuticals. Pharmaceutical Schedule. Effective 1 July for Hospital. Update effective 1 March 2016

Section H. Pharmaceuticals. Pharmaceutical Schedule. Effective 1 July for Hospital. Update effective 1 March 2016 The Hospital Medicines List (HML) Section H for Hospital Pharmaceuticals Pharmaceutical Management Agency Update effective 1 March 2016 Update New Cumulative Zealand for December 2015, January, February

More information

Section H. Pharmaceuticals. Pharmaceutical Schedule. Effective 1 July for Hospital. Update effective 1 January 2016

Section H. Pharmaceuticals. Pharmaceutical Schedule. Effective 1 July for Hospital. Update effective 1 January 2016 The Hospital Medicines List (HML) Section H for Hospital Pharmaceuticals Pharmaceutical Management Agency Update effective 1 January 2016 Update New Cumulative Zealand for December 2015 and January 2016

More information

Update New Zealand Pharmaceutical Schedule Effective 1 February 2018 Cumulative for January and February 2018

Update New Zealand Pharmaceutical Schedule Effective 1 February 2018 Cumulative for January and February 2018 Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 February Cumulative for January and February Contents Summary of PHARMAC decisions effective 1 February... 3 New

More information

Update New Zealand Pharmaceutical Schedule Effective 1 May 2018

Update New Zealand Pharmaceutical Schedule Effective 1 May 2018 Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 May Contents Summary of PHARMAC decisions effective 1 May... 3 New tender listings for 1 May... 4 New listings...

More information

NB Drug Plans Formulary Update

NB Drug Plans Formulary Update Bulletin #973 April 30, 2018 NB Drug Plans Formulary Update Generic drug product updates included in this bulletin: Generic drug product additions - New generic products will be reimbursed up to the category

More information

(price) Underlined indicates tender winning product now available at new subsidy $5.62 $4.89. $2.35 (Manuf price $5.26) $2.59

(price) Underlined indicates tender winning product now available at new subsidy $5.62 $4.89. $2.35 (Manuf price $5.26) $2.59 Sole Supply - Pending Changes Quick Reference 1 *** Sorted by Sole *** Chemical Type, Strength, Pack Size Pharmacode Current New Tender of New of Sole Supply and Reference Start Thiamine hydrochloride

More information

Update. New Zealand Pharmaceutical Schedule. Effective 1 November Cumulative for September, October and November 2018

Update. New Zealand Pharmaceutical Schedule. Effective 1 November Cumulative for September, October and November 2018 Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 November 2018 Cumulative for September, October and November 2018 Contents Summary of PHARMAC decisions effective

More information

Release of the 2013/14 Invitation to Tender

Release of the 2013/14 Invitation to Tender 07 November 2013 Release of the 2013/14 Invitation to Tender The 2013/14 Invitation to Tender (2013/14 ITT) has been distributed today via the electronic tender (etender) system. If you do not receive

More information

Approval of Multiple Diabetes Management Products and Mesalazine proposals

Approval of Multiple Diabetes Management Products and Mesalazine proposals 8 June Approval of Multiple Diabetes Management Products and Mesalazine proposals PHARMAC is pleased to announce the approval of five agreements in relation to funding of blood glucose, blood glucose diagnostic

More information

February Introducing PHARMAC 2. Part I General Rules 5

February Introducing PHARMAC 2. Part I General Rules 5 February 2018 Volume 6 Number 1 Editor: Kaye Wilson & Doris Chong email: enquiry@pharmac.govt.nz Telephone +64 4 460 4990 Facsimile +64 4 460 4995 Level 9, 40 Mercer Street PO Box 10 254 Wellington 6143

More information

Update New Zealand Pharmaceutical Schedule

Update New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 December 2018 Cumulative for September, October, November and December 2018 Contents Summary of PHARMAC decisions

More information

Update New Zealand Pharmaceutical Schedule Effective 1 September 2016

Update New Zealand Pharmaceutical Schedule Effective 1 September 2016 Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 September 2016 Contents Summary of PHARMAC decisions effective 1 September 2016... 3 What s changing?... 5 Pembrolizumab

More information

Special Generic Drug Pricing Program

Special Generic Drug Pricing Program FREE PICK-UP & DELIVERY Flu-Shots Specialty prescription Compounding Wellness center providing health screenings for hypertension and diabetes $3 Special Generic Prescription Drug Program only offered

More information

Update New Zealand Pharmaceutical Schedule

Update New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 December 2017 Cumulative for September, October, November and December 2017 Contents Summary of PHARMAC decisions

More information

Section H. Pharmaceuticals. New Zealand. Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML)

Section H. Pharmaceuticals. New Zealand. Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML) The Hospital Medicines List (HML) Section H for Hospital Pharmaceuticals Pharmaceutical Management Agency Update Update effective 1 June 2014 New Zealand Cumulative for April, May and June 2014 Pharmaceutical

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 July 2014 Cumulative for May, June and July 2014 Contents Summary of PHARMAC decisions effective 1 July 2014... 3

More information

Update New Zealand Pharmaceutical Schedule Effective 1 January 2018

Update New Zealand Pharmaceutical Schedule Effective 1 January 2018 Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 January Contents Summary of PHARMAC decisions effective 1 January... 3 New tender listings for 1 January... 5 New

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 January Contents Summary of PHARMAC decisions effective 1 January... 4 What s changing?... 6 Metoprolol succinate

More information

Update New Zealand Pharmaceutical Schedule Effective 1 January 2019

Update New Zealand Pharmaceutical Schedule Effective 1 January 2019 Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 January Contents Summary of PHARMAC decisions effective 1 January... 4 News Stories January Update... 6 New listings...

More information

OPHTHALMIC GENERIC FORMULATIONS BY ADREA R. BENKOFF, M.D.

OPHTHALMIC GENERIC FORMULATIONS BY ADREA R. BENKOFF, M.D. OPHTHALMIC GENERIC FORMULATIONS BY ADREA R. BENKOFF, M.D. WHAT YOU NEED TO KNOW ABOUT OPHTHALMIC GENERICS GENERIC REQUIREMENTS WHO MAKES GENERIC OPHTHALMIC PRODUCTS DO THEY WORK AS WELL AS THE BRAND PRODUCT

More information

REQUEST FOR PROPOSALS SUPPLY OF NICOTINE REPLACEMENT THERAPY

REQUEST FOR PROPOSALS SUPPLY OF NICOTINE REPLACEMENT THERAPY 16 October 2013 Dear Supplier REQUEST FOR PROPOSALS SUPPLY OF NICOTINE REPLACEMENT THERAPY PHARMAC invites proposals for the supply of nicotine replacement therapy (including, but not limited to, nicotine

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 October 2014 Cumulative for September and October 2014 Contents Summary of PHARMAC decisions effective 1 October

More information

RETAIL PRESCRIPTION PROGRAM DRUG LIST -- WALMART Revised 8/24/11

RETAIL PRESCRIPTION PROGRAM DRUG LIST -- WALMART Revised 8/24/11 Allergies & Cold and Flu $4, 30-day $10, 90-day Benzonatate 100mg cap 14 42 Loratadine 10mg tab 30 90 Promethazine DM syrup 120ml 360ml Antibiotic Treatments Amoxicillin 125mg/5ml susp (80ml bottle) 1

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 August 2014 Cumulative for May, June, July, and August 2014 Contents Summary of PHARMAC decisions effective 1 August

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs CADUET (amlodipine besylate/atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have

More information

Decision relating to the funding of TNF inhibitors (Humira and Enbrel) and gabapentin (Neurontin)

Decision relating to the funding of TNF inhibitors (Humira and Enbrel) and gabapentin (Neurontin) 9 September 2015 Decision relating to the funding of TNF inhibitors (Humira and Enbrel) and gabapentin (Neurontin) The PHARMAC Board has approved the proposal relating to the funding of the TNF-inhibitor

More information

Tamsulosin Hydrochloride 0.4 mg Capsule

Tamsulosin Hydrochloride 0.4 mg Capsule Tamsulosin Hydrochloride 0.4 mg Capsule, Tamsulosin Hydrochloride 0.4 mg Capsule India, Tamsulosin Hydrochloride 0.4 mg Capsule manufacturers India, side effects Tamsulosin Hydrochloride 0.4 mg Capsule

More information

Home Delivery Prescription Program Drug List

Home Delivery Prescription Program Drug List Home Delivery Prescription Program Drug List Low-cost prescriptions, right in your mailbox. Now you can have your generic prescriptions mailed right to your home, no matter where you live. Because we think

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 September 2014 Contents Summary of PHARMAC decisions effective 1 September 2014... 3 Erythropoietin changes to subsidy...

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 April Cumulative for January, February, March and April Contents Summary of PHARMAC decisions effective 1 April...

More information

NB Drug Plans Formulary Update

NB Drug Plans Formulary Update Bulletin #960 October 31, 2017 NB Drug Formulary Update Please find attached a list of generic drug product updates for the New Brunswick Drug Formulary. Generic drug product additions New generic products

More information

RECALL NOTICES 2013 PLEASE CHECK YOUR RECALL LETTER TO VERIFY PRODUCT NDC LOT NUMBERS

RECALL NOTICES 2013 PLEASE CHECK YOUR RECALL LETTER TO VERIFY PRODUCT NDC LOT NUMBERS RECALL NOTICES 2013 PLEASE CHECK YOUR RECALL LETTER TO VERIFY PRODUCT NDC LOT NUMBERS Dec 13, 2013 DR. Reddy recalls to the RETAIL Level Metoprolol Succinate ER Tablets 50mg 100 55111-0467-01 C207416 C207420

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 October 2013 Cumulative for September and October 2013 Contents Summary of PHARMAC decisions effective 1 October

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 September 2013 Contents Summary of PHARMAC decisions effective 1 September 2013... 3 New brand of enalapril maleate

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 May Contents Summary of PHARMAC decisions effective 1 May... 3 Diabetes Nurses Prescribers... 4 Tacrolimus brand

More information

Update New Zealand Pharmaceutical Schedule Effective 1 March 2017 Cumulative for January, February and March 2017

Update New Zealand Pharmaceutical Schedule Effective 1 March 2017 Cumulative for January, February and March 2017 Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 March Cumulative for January, February and March Contents Summary of PHARMAC decisions effective 1 March... 3 What

More information

Published by the Pharmaceutical Services Division to provide information for British Columbia s health care providers

Published by the Pharmaceutical Services Division to provide information for British Columbia s health care providers Published by the Pharmaceutical Services Division to provide information for British Columbia s health care providers QuickLinks Keeping the Lines Clear... 1 Newsletter Notification Service... 1 Special

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 November 2010 Cumulative for September, October and November 2010 Section H cumulative for August, September, October

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs ARTHROTEC (diclofenac sodium/misoprostol) tablets This list does not imply that the products on this chart are interchangeable or have the same

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs ZOLOFT (sertraline hydrochloride) tablets, for oral use This list does not imply that the products on this chart are interchangeable or have the

More information

Home Delivery Prescription Program Drug List

Home Delivery Prescription Program Drug List Home Delivery Prescription Program Drug List Low-cost prescriptions, right in your mailbox. Now you can have your generic prescriptions mailed right to your home, no matter where you live. Because we think

More information

Update New Zealand Pharmaceutical Schedule Effective 1 September 2017

Update New Zealand Pharmaceutical Schedule Effective 1 September 2017 Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 September 2017 Contents Summary of PHARMAC decisions effective 1 September 2017... 3 New listings... 5 Temozolomide

More information

BC PharmaCare Newsletter

BC PharmaCare Newsletter BC PharmaCare ewsletter August 24, 2010 Edition 10-009 Published by the Pharmaceutical Services Division to provide information for British Columbia s health care providers QuickLinks Pharmacy Services

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 January Contents Summary of PHARMAC decisions effective 1 January... 3 Removal of Special Authority from Seretide...

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 July 2013 Cumulative for May, June and July 2013 Contents Summary of PHARMAC decisions effective 1 July 2013... 3

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs LIPITOR (atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have the same efficacy or

More information

PRESCRIPTION SAVINGS CLUB FLAT- PRICED GENERIC DRUG LIST (EMDEON) Effective August 20, 2014

PRESCRIPTION SAVINGS CLUB FLAT- PRICED GENERIC DRUG LIST (EMDEON) Effective August 20, 2014 PRESCRIPTION SAVINGS CLUB FLAT- PRICED GENERIC DRUG LIST (EMDEON) Effective August 20, 2014 The Prescription Savings Club provides its members with significant savings on prescription medications. The

More information

COMMERCIAL BULLETIN. Inside this issue. Anticoagulants recommended over Aspirin

COMMERCIAL BULLETIN. Inside this issue. Anticoagulants recommended over Aspirin COMMERCIAL BULLETIN Monthly service July 2015 Anticoagulants recommended over Aspirin Patients who suffer from atrial fibrillation (AF) should be prescribed Anticoagulants and not Aspirin says National

More information

UPDATE. New Zealand Pharmaceutical Schedule

UPDATE. New Zealand Pharmaceutical Schedule 07 UPDATE New Zealand Pharmaceutical Schedule Effective 1 November 2007 Cumulative for September, October and November 2007 Section H cumulative for August, September, October and November 2007 Contents

More information

Updates to the Alberta Drug Benefit List. Effective February 1, 2018

Updates to the Alberta Drug Benefit List. Effective February 1, 2018 Updates to the Alberta Drug Benefit List Effective February 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)

More information

Calgary Long Term Care Formulary. Pharmacy & Therapeutics. February 2015

Calgary Long Term Care Formulary. Pharmacy & Therapeutics. February 2015 Calgary Long Term Care Formulary Pharmacy & Therapeutics February 2015 Highlights http://www.albertahealthservices.ca/4070.aspx 1 Contents February 2016... 3 Added Product(s)... 3 Not Listed, Delisted

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs ARTHROTEC (diclofenac sodium/misoprostol) tablets This list does not imply that the products on this chart are interchangeable or have the same

More information

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS The benefits of prefilled syringes for palliative care from the hospital pharmacy service In

More information

Proposals regarding the Cholesterol Lowering Pharmaceuticals Atorvastatin and Ezetimibe

Proposals regarding the Cholesterol Lowering Pharmaceuticals Atorvastatin and Ezetimibe 26 April 2010 Proposals regarding the Cholesterol Lowering Pharmaceuticals Atorvastatin and Ezetimibe PHARMAC is seeking feedback on the following proposals relating to the cholesterol lowering pharmaceuticals

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 December 2013 Cumulative for September, October, November and December 2013 Contents Summary of PHARMAC decisions

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 May Contents Summary of PHARMAC decisions effective 1 May... 3 Abiraterone acetate (Zytiga) new listing... 5 Actavis

More information

Proposal on subsidy changes for some respiratory inhalation products and access restrictions to combination inhalers.

Proposal on subsidy changes for some respiratory inhalation products and access restrictions to combination inhalers. 30 August 2011 Proposal on changes for some respiratory products and access restrictions to combination inhalers. As notified on 16 June 2011, PHARMAC has been considering options for managing the funding

More information

Price List Effective 1June 2011.

Price List Effective 1June 2011. Price List Effective 1June 2011. Price list updated - new product Nexiam 10 mg sachets. NAPPI SCH PRODUCT PACK ANTIBIOTICS MERONEM 820636010 S4 Meronem 500mg vials 1 Vial R 229.20 R 261.29 820644013 S4

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - February 2015 Effective February 26, 2015 Ministry of Health and Long-Term Care Table of Contents New Multi-Source

More information

Legal Supplement Part B Vol. 57, No. 6 18th January, NOTIFICATION NOTICE OF APPROVAL IN RESPECT OF NEW DRUGS

Legal Supplement Part B Vol. 57, No. 6 18th January, NOTIFICATION NOTICE OF APPROVAL IN RESPECT OF NEW DRUGS Legal Supplement Part B Vol. 57, No. 6 18th January, 2018 11 LEGAL NOTICE NO. 5 REPUBLIC OF TRINIDAD AND TOBAGO FOOD AND DRUGS ACT, CHAP. 30:01 NOTIFICATION NOTICE OF APPROVAL IN RESPECT OF NEW DRUGS ISSUED

More information

Influenza Immunization Drug Cards. New Brunswick (2017/18)

Influenza Immunization Drug Cards. New Brunswick (2017/18) Influenza Immunization Drug Cards New Brunswick (2017/18) Contents Identifying Duplicate Drug Records... 1 Fluzone Quadrivalent - Pack Size 0.5... 3 Main Drug Card... 9 General Tab... 10 Plans Tab... 10

More information

Palliative Coverage Drug Benefit Supplement

Palliative Coverage Drug Benefit Supplement Palliative Coverage Drug Benefit Supplement Effective April 1, 2017 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)

More information

To: Medical Groups, DHB Hospital Pharmacies and Interested Parties

To: Medical Groups, DHB Hospital Pharmacies and Interested Parties 24 September 2008 To: Medical Groups, DHB Hospital Pharmacies and Interested Parties CONSULTATION ON TENDER OF CERTAIN PHARMACEUTICALS ALL RESPONSES DUE BY 5PM, WEDNESDAY 5 NOVEMBER 2008 In accordance

More information

RECALL NOTICES 2014 PLEASE CHECK YOUR RECALL LETTER TO VERIFY PRODUCT NDC LOT NUMBERS

RECALL NOTICES 2014 PLEASE CHECK YOUR RECALL LETTER TO VERIFY PRODUCT NDC LOT NUMBERS RECALL NOTICES 2014 PLEASE CHECK YOUR RECALL LETTER TO VERIFY PRODUCT NDC LOT NUMBERS Aug 28, 2014 Fougera recalls to the WHOLESALE Level Fluocinonde Gel USP 60gm 00168-0135-60 Multiple Lots Fluocinonde

More information

Information for Vermont Prescribers of Prescription Drugs Long Form Fetzima (levomilnacipran) Extended Release Capsules

Information for Vermont Prescribers of Prescription Drugs Long Form Fetzima (levomilnacipran) Extended Release Capsules Information for Vermont Prescribers of Prescription Drugs Long Form Fetzima (levomilnacipran) Extended Release Capsules The prices listed below are Average Wholesale Prices ( AWP ) as established and made

More information

Update New Zealand Pharmaceutical Schedule Effective 1 July 2018 Cumulative for May, June and July 2018

Update New Zealand Pharmaceutical Schedule Effective 1 July 2018 Cumulative for May, June and July 2018 Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 July 2018 Cumulative for May, June and July 2018 Contents Summary of PHARMAC decisions effective 1 July 2018... 4

More information

LIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR (Non-Prequalified Items) A: Injection Antimicrobials Sr. No.

LIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR (Non-Prequalified Items) A: Injection Antimicrobials Sr. No. LIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR 2017-2018 (Non-Prequalified Items) A: Injection Antimicrobials Sr. 1 Amphotericin B vial of 50mg with wfi individually packed in carton with 2 Artemether 80mg/ml

More information

Advance Notification of Amendments to the April 2017 Drug Tariff

Advance Notification of Amendments to the April 2017 Drug Tariff Advance Notification of Amendments to the April 2017 Drug Tariff ADDITIONS Part I - Drugs And Preparations * This pack only (others already available) Special Container Drug Qty Price * Dipyridamole 200mg

More information